drugset / Trial / NCT02281383
Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a phase II study. This means that BCG therapy has already been found to be safe in humans. The investigators just want to see if using more treatments works better.
Timeline
- Start
- 2014-10
- Primary completion
- 2022-02-24
- Completion
- 2022-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacillus Calmette-Guérin | Vaccine | — | Other |